Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Equity Average: 2009-2024

Historic Equity Average for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $6.2 billion.

  • UNITED THERAPEUTICS's Equity Average rose 16.66% to $6.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 billion, marking a year-over-year increase of 16.66%. This contributed to the annual value of $6.2 billion for FY2024, which is 15.28% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Equity Average of $6.2 billion as of FY2024, which was up 15.28% from $5.4 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Equity Average registered a high of $6.2 billion during FY2024, and its lowest value of $3.1 billion during FY2020.
  • For the 3-year period, UNITED THERAPEUTICS's Equity Average averaged around $5.3 billion, with its median value being $5.4 billion (2023).
  • Data for UNITED THERAPEUTICS's Equity Average shows a peak YoY grew of 23.14% (in 2023) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Equity Average (Yearly) stood at $3.1 billion in 2020, then increased by 19.08% to $3.7 billion in 2021, then grew by 19.06% to $4.4 billion in 2022, then grew by 23.14% to $5.4 billion in 2023, then climbed by 15.28% to $6.2 billion in 2024.